SLU-PP-332 is an investigational ERRα/ERRγ agonist under study in metabolic and exercise-mimetic research. Often referred to as an “exercise-mimetic” compound in preclinical literature.
Research Profile
- ERRα/ERRγ selective agonist
- Studied in exercise-mimetic and metabolic research models
- Investigated in mitochondrial and oxidative-tissue research
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: SLU-PP-332
- Dosage: 5 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
